AAAAAA
Results: 1-25/29
Authors:
NEIJT JP
ENGELHOLM SA
TUXEN M
SORENSEN PG
HANSEN M
SESSA C
DESWART CAM
HIRSCH FR
WITTEVEEN PO
LUND B
HANSEN SW
PALLE B
ROER O
VANHOUWELINGEN HC
Citation: Jp. Neijt et al., PACLITAXEL-CISPLATIN VS. PACLITAXEL-CARBOPLATIN IN PREVIOUSLY UNTREATED OVARIAN-CANCER, Annals of oncology, 9, 1998, pp. 312-312
Authors:
DEWIT R
STOTER G
SLEIJFER D
NEIJT JP
HUININK WWT
DEPRIJCK L
COLLETTE L
SYLVESTER R
Citation: R. Dewit et al., 4 CYCLES OF BEP VS 4 CYCLES OF VIP IN PATIENTS WITH INTERMEDIATE-PROGNOSIS METASTATIC TESTICULAR NON SEMINOMA - A RANDOMIZED STUDY OF THE EORTC GENITOURINARY TRACT CANCER COOPERATIVE GROUP, British Journal of Cancer, 78(6), 1998, pp. 828-832
Authors:
NEIJT JP
Citation: Jp. Neijt, OVARIAN-CANCER - PROGRESS IN CHEMOTHERAPY, European journal of cancer, 33, 1997, pp. 622-622
Authors:
NEIJT JP
ENGELHOLM SA
WITTEVEEN PO
TUXEN MK
SORENSEN PG
HANSEN M
HIRSCH F
SESSA C
DESWART C
VANHOUWELINGEN HC
LUND B
HANSEN SW
Citation: Jp. Neijt et al., PACLITAXEL (175 MG M(2) OVER 3 HOURS) WITH CISPLATIN OR CARBOPLATIN IN PREVIOUSLY UNTREATED OVARIAN-CANCER - AN INTERIM ANALYSIS/, Seminars in oncology, 24(5), 1997, pp. 36-39
Authors:
HAMERS FPT
PLANTINGA LC
VERHAAGEN J
NEIJT JP
GISPEN WH
Citation: Fpt. Hamers et al., UP-REGULATION OF B50 GAP-43 PROTEIN MESSENGER-RNA IN RAT DORSAL-ROOT GANGLIA DURING CISPLATIN INTOXICATION/, Journal of neuroscience research, 44(2), 1996, pp. 142-148
Authors:
NEIJT JP
LUND B
Citation: Jp. Neijt et B. Lund, PACLITAXEL WITH CARBOPLATIN FOR THE TREATMENT OF OVARIAN-CANCER, Seminars in oncology, 23(6), 1996, pp. 2-4
Authors:
LUND B
NEIJT JP
Citation: B. Lund et Jp. Neijt, GEMCITABINE IN CISPLATIN-RESISTANT OVARIAN-CANCER, Seminars in oncology, 23(5), 1996, pp. 72-76
Authors:
NEIJT JP
Citation: Jp. Neijt, NEW THERAPY FOR OVARIAN-CANCER, The New England journal of medicine, 334(1), 1996, pp. 50-51
Authors:
BRINKHUIS M
BAAK JPA
MEIJER GA
VANDIEST PJ
MOGENSEN O
BICHEL P
NEIJT JP
Citation: M. Brinkhuis et al., VALUE OF QUANTITATIVE PATHOLOGICAL VARIABLES AS PROGNOSTIC FACTORS INADVANCED OVARIAN-CARCINOMA, Journal of Clinical Pathology, 49(2), 1996, pp. 142-148
Authors:
NEIJT JP
Citation: Jp. Neijt, OVARIAN-CANCER - NEW INSIGHTS INTO SYSTEMIC THERAPY, European journal of cancer, 31A(5), 1995, pp. 823-824
Authors:
NEIJT JP
Citation: Jp. Neijt, OVARIAN-CANCER - NEW INSIGHTS INTO SYSTEMIC THERAPY, European journal of cancer, 31A, 1995, pp. 296-296
Authors:
LUND B
HANSEN OP
NEIJT JP
THEILADE K
HANSEN M
Citation: B. Lund et al., PHASE-II STUDY OF GEMCITABINE IN PREVIOUSLY PLATINUM-TREATED OVARIAN-CANCER PATIENTS, Anti-cancer drugs, 6, 1995, pp. 61-62
Authors:
NEIJT JP
Citation: Jp. Neijt, INTERVAL CYTOREDUCTION IN OVARIAN-CANCER, The New England journal of medicine, 333(4), 1995, pp. 254-255
Authors:
NEIJT JP
LACAVE AJ
SPLINTER TAW
TAAL BG
VEENHOF CHN
SAHMOUD T
LIPS CJM
Citation: Jp. Neijt et al., MITOXANTRONE IN METASTATIC APUDOMAS - A PHASE-II STUDY OF THE EORTC GASTROINTESTINAL CANCER COOPERATIVE GROUP, British Journal of Cancer, 71(1), 1995, pp. 106-108
Authors:
LUND B
HANSEN OP
THEILADE K
HANSEN M
NEIJT JP
Citation: B. Lund et al., PHASE-II STUDY OF GEMCITABINE (2',2'-DIFLUORODEOXYCYTIDINE) IN PREVIOUSLY TREATED OVARIAN-CANCER PATIENTS, Journal of the National Cancer Institute, 86(20), 1994, pp. 1530-1533
Authors:
VANDIEST PJ
BAAK JPA
BRUGGHE J
VANDEBURG MEL
VANOOSTEROM AT
NEIJT JP
Citation: Pj. Vandiest et al., QUANTITATIVE PATHOLOGICAL FEATURES AS PREDICTORS OF LONG-TERM SURVIVAL IN PATIENTS WITH ADVANCED OVARIAN-CANCER TREATED WITH CISPLATIN, International journal of gynecological cancer, 4(3), 1994, pp. 174-179
Authors:
VANGERVEN JMA
HOVESTADT A
MOLL JWB
RODENBURG CJ
SPLINTER TAW
VANOOSTEROM AT
KEIZER L
DROGENDIJK TE
GROENHOUT CM
VECHT CJ
NEIJT JP
Citation: Jma. Vangerven et al., THE EFFECTS OF AN ACTH-[4-9] ANALOG ON DEVELOPMENT OF CISPLATIN NEUROPATHY IN TESTICULAR CANCER - A RANDOMIZED TRIAL, Journal of neurology, 241(7), 1994, pp. 432-435
Authors:
VANDERHOOP RG
HAMERS FPT
NEIJT JP
VELDMAN H
GISPEN WH
JENNEKENS FGI
Citation: Rg. Vanderhoop et al., PROTECTION AGAINST CISPLATIN-INDUCED NEUROTOXICITY BY ORG-2766 - HISTOLOGICAL AND ELECTROPHYSIOLOGICAL EVIDENCE, Journal of the neurological sciences, 126(2), 1994, pp. 109-115
Authors:
VANDERHOOP RG
HAMERS FPT
NEIJT JP
VELDMAN H
GISPEN WH
JENNEKENS FGI
Citation: Rg. Vanderhoop et al., PROTECTION AGAINST CISPLATIN-INDUCED NEUROTOXICITY BY ORG-2766 - HISTOLOGICAL AND ELECTROPHYSIOLOGICAL EVIDENCE, Journal of the neurological sciences, 126(2), 1994, pp. 109-115
Authors:
TAAL BG
AUDISIO RA
BLEIBERG H
BLIJHAM GH
NEIJT JP
VEENHOF CHN
DUEZ N
SAHMOUD T
Citation: Bg. Taal et al., PHASE-II TRIAL OF MITOMYCIN-C (MMC) IN ADVANCED GALLBLADDER AND BILIARY TREE CARCINOMA - AN EORTC GASTROINTESTINAL-TRACT-CANCER-COOPERATIVE-GROUP STUDY, Annals of oncology, 4(7), 1993, pp. 607-609
Authors:
NEIJT JP
Citation: Jp. Neijt, THE CHALLENGE OF DOSE-INTENSITY IN OVARIAN-CANCER, Annals of oncology, 4(5), 1993, pp. 349-350
Authors:
KAPPEN HJ
NEIJT JP
Citation: Hj. Kappen et Jp. Neijt, NEURAL-NETWORK ANALYSIS TO PREDICT TREATMENT OUTCOME, Annals of oncology, 4, 1993, pp. 31-34
Authors:
DEVRIES EGE
HAMILTON TC
LIND M
DAUPLAT J
NEIJT JP
OZOLS RF
Citation: Ege. Devries et al., DRUG-RESISTANCE, SUPPORTIVE CARE AND DOSE INTENSITY, Annals of oncology, 4, 1993, pp. 57-62
Authors:
HANSEN HH
EISENHAUER EA
HANSEN M
NEIJT JP
PICCART MJ
SESSA C
THIGPEN JT
Citation: Hh. Hansen et al., NEW CYTOSTATIC DRUGS IN OVARIAN-CANCER, Annals of oncology, 4, 1993, pp. 63-70
Authors:
ALLEN DG
BAAK J
BELPOMME D
BEREK JS
BERTELSEN K
HUININK WWT
VANDERBURG MEL
CALVERT AH
CONTE PE
DAUPLAT J
EISENHAUER EA
FAVALLI G
HACKER NF
HAMILTON TC
HANSEN HH
HANSEN M
VANHOUWELINGEN HC
KAYE SB
LEVIN L
LUND B
NEIJT JP
OZOLS RF
PICCART MJ
RUSTIN GJS
SESSA C
SOUTTER WP
THIGPEN JT
TROPE C
VERMORKEN JB
DEVRIES EGE
Citation: Dg. Allen et al., ADVANCED EPITHELIAL OVARIAN-CANCER - 1993 CONSENSUS STATEMENTS, Annals of oncology, 4, 1993, pp. 83-88